Antisense LNA GapmeR ivr (15)

QIAGEN offers a range of single-strand antisense oligonucleotides (ASOs) within its Antisense LNA GapmeR family, intended for mRNA and lncRNA silencing in cell culture and animal models. These ASOs use LNA technology to drive knockdown of target RNAs via RNase H-dependent degradation of complementary sequences.

This particular configuration is the in vivo Ready grade, supplied at ≥75% purity. It is designed to deliver specific knockdown without the off-target activity associated with RISC-based mechanisms, and the oligo sequence can be specified to the user's intended RNA target through the Geneglobe site.

Within QIAGEN's catalogue structure, the product sits in the Assay Technologies portfolio group and is classified as a Consumable item.